Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine.

The proliferative activity of normal acinar and ductal breast epithelial cells was studied by in vivo labeling with 5-bromodeoxyuridine (BrdUrd) in 26 cases with concurrent breast carcinoma. The BrdUrd-labeled cells were recognized in histologic sections of paraffin-embedded tissue, using an anti-BrdUrd antibody and an immunoperoxidase reaction. The percentage of BrdUrd-labeled cells showed great variability for both acinar (0% to 2.66%; mean, 0.70%; standard deviation [SD], 0.80%) and ductal cells (0% to 1.99%; mean, 0.51%; SD, 0.57%). The fraction of proliferating epithelial cells declined with the age of the patients and was significantly higher in premenopausal women (1.16% +/- 0.85% for acinar and 0.94% +/- 0.60% for ductal cells) as compared with the postmenopausal women (0.27% +/- 0.46% for acinar and 0.17% +/- 0.22% for ductal cells), P less than 0.01 for acinar and P less than 0.001 for ductal cells, respectively. In some patients, great variability in distribution of proliferating acinar and ductal cells among different lobules and ducts was observed. No difference was found in the number of proliferating acinar and ductal cells situated near or far from their corresponding tumors. No correlation was seen between cell proliferation of normal acinar or ductal cells and cell proliferation of the respective tumors.

[1]  O. Kallioniemi,et al.  Evaluation of cell proliferation in breast carcinoma. Comparison of Ki‐67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count , 1990, Cancer.

[2]  K. McPherson,et al.  Oral contraceptive use influences resting breast proliferation. , 1989, Human pathology.

[3]  A. Howell,et al.  The effect of age and menstrual cycle upon proliferative activity of the normal human breast. , 1988, British Journal of Cancer.

[4]  F. Waldman,et al.  Clinical applications of the bromodeoxyuridine/DNA assay. , 1988, Cytometry. Supplement : the journal of the Society for Analytical Cytology.

[5]  T. Anderson,et al.  Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. , 1988, The American journal of pathology.

[6]  W Heidenreich,et al.  The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma , 1987, Cancer.

[7]  J. Smith,et al.  Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells. , 1986, The American journal of pathology.

[8]  G. Raab,et al.  Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. , 1982, British Journal of Cancer.

[9]  J. Meyer,et al.  Cell proliferation in fibrocystic disease and postmenopausal breast ducts measured by thymidine labeling , 1982, Cancer.

[10]  T. Anderson,et al.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. , 1981, British Journal of Cancer.

[11]  F. Vogel,et al.  The correlation of histologic changes in the human breast with the menstrual cycle. , 1981, The American journal of pathology.

[12]  J. Masters,et al.  Cyclic Variation of DNA synthesis in human breast epithelium. , 1977, Journal of the National Cancer Institute.

[13]  J. Meyer.  Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. , 1977, Human pathology.